These novel medications , Retatrutide, represent a groundbreaking advancement in treating metabolic dysfunction and possibly related conditions . They are classified as GLP-1 hormone agonists , meaning https://ellacgjl827728.glifeblog.com/40086518/tirzepatide-a-comprehensive-dive-into-incretin-compounds